blockchain

AI Verification Loops: Recursive Reasoning Patterns Boost Model Accuracy from 73% to 94%

According to God of Prompt on Twitter, the implementation of verification loops in AI models—where the system recursively checks its answers using different reasoning modes such as backward ...
IEEE

A Novel Method to Determine Low-Weight Input Patterns of Recursive Systematic Convolutional Codes

Abstract: In this research paper, we present a novel method for obtaining the patterns of inputs that generate low-weight codewords in Recursive Systematic Convolutional (RSC) codes, hereafter ...
Frontiers

Visual recursion without recursive language? a case study of a minimally verbal autistic child

The human faculty to generate an infinite set of structured expressions in language, present in most cultures and normal ontogeny, is the most substantial evidence of the human capacity for recursion.
Nasdaq

MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy

Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free energy perturbation (FEP) calculations but at ...
marktechpost

Relaxed Recursive Transformers with Layer-wise Low-Rank Adaptation: Achieving High Performance and Reduced Computational Cost in Large Language Models

Large language models (LLMs) rely on deep learning architectures that capture complex linguistic relationships within layered structures. Primarily based on Transformer architectures, these models are ...
BioSpace

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides ...

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...
GEN

Recursion to Acquire Exscientia, Combining AI Drug Pioneers

Recursion Pharmaceuticals has agreed to acquire the Oxford, U.K.-based artificial intelligence (AI) drug pioneer Exscientia, the companies said today, in a deal that consolidates two leaders in ...